




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>SCD/Ventricular Arrhythmias</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=cef7f268-5201-449f-829a-cd37615b5acf</link>
        <description>Clinical Topic Feed: SCD/Ventricular Arrhythmias</description>
        <language>en</language>

        

                <item>
                    <title>FinACAF: Stroke Risk Lower in AFL-Only vs. AFib-Only Patients</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/09/16/15/19/FinACAF</link>                    <description>Patients with atrial flutter only (AFL-only) had a 40% lower risk of ischemic stroke than those with atrial fibrillation only (AFib-only), based on results from the FinACAF study published Sept. 3 in EHJ.</description>
                    <pubdate>1789650840000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACCEL Lite: Insights From the PVI-SHAM-AF</title>
<link>/Latest-in-Cardiology/Articles/2026/09/15/13/24/accel-lite-15sep2026</link>                    <description>In this episode, Clyde W. Yancy, MD, MACC and Rolf Wachter, MD discuss the results of &#226;€œPVI-SHAM-AF: Pulmonary vein isolation versus SHAM in AF&#226;€.</description>
                    <pubdate>1789479180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement from the American College of Cardiology and the American Heart Association</title>
<link>https://www.jacc.org/doi/10.1016/j.jacc.2026.07.003</link>                    <description></description>
                    <pubdate>1788458400000</pubdate>
                    <category>Guidelines</category>
                </item>
                <item>
                    <title>ACC/AHA Scientific Statement Focuses on CV Risk Evaluation, Management For Tactical Athletes</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/09/03/15/11/ACC-AHA-Scientific-Statement-Focuses-on-CV-Risk-Evaluation-Management-For-Tactical-Athletes</link>                    <description>A new ACC/AHA Scientific Statement provides the first comprehensive framework for cardiovascular evaluation and management of tactical athletes, including the more than 4 million Americans currently serving as military personnel, firefighters, law enforcement officers, EMS professionals, pilots and astronauts.</description>
                    <pubdate>1788458400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | Lifestyle Intervention Effective in Prediabetes; Aficamten Tops Metoprolol For Exercise in oHCM; More</title>
<link>/Latest-in-Cardiology/Articles/2026/09/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1788264540000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>DISCO, LAACS-2, PRAGUE-26, HeartRunner: Insights on Cardiac Arrest, PE, and Surgical Outcomes</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-902am-disco-laacs2-prague26-heartrunner-esc-2026</link>                    <description>Hot Line studies from ESC Congress 2026 highlight the complexity of improving cardiovascular outcomes, with new evidence refining the role of immediate coronary angiography after cardiac arrest, identifying which patients benefit from left atrial appendage (LAA) closure during cardiac surgery, advancing treatment options for pulmonary embolism (PE), and questioning the impact of community first-responder activation on short-term cardiac arrest survival.</description>
                    <pubdate>1788182580000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ASPIRED, DANISH-CRT, and His-Alternative II Examine Syncope, CRT Strategies</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-315am-comboep-esc-2026</link>                    <description>Three Hot Line trials from ESC Congress 2026 &#226;€“ ASPIRED, DANISH-CRT, and His-Alternative II &#226;€“ test 14-day ECG monitoring in patients with unexplained syncope, compare cardiac resynchronization therapy (CRT) modalities, and assess targeted left ventricular lead placement at the site of latest electrical activation in patients with heart failure and prolonged QRS.</description>
                    <pubdate>1788168300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>IDEAL-AF, NEXAF, PVI-SHAM-AF Provide New Evidence on Interventions That Could Improve AFib Management</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-11am-comboaf-esc-2026</link>                    <description>Three new studies presented during ESC Congress 2026 are shedding light on how best to treat and manage atrial fibrillation (AFib). From catheter ablation strategies to rhythm-control procedures and tailored exercise programs, the IDEAL-AF, NEXAF and PVI-SHAM-AF trials provide fresh evidence on interventions that could improve outcomes and quality of life.</description>
                    <pubdate>1788102900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PADN-HF-PH: Pulmonary-Artery Denervation For Pulmonary Hypertension Associated With Left Heart Disease and HF</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-324am-padn-esc-2026</link>                    <description>Pulmonary-artery denervation, in addition to guideline-directed medical therapy, resulted in fewer events of clinical worsening than medical therapy alone in patients with pulmonary hypertension associated with left heart disease and heart failure (HF), based on findings from the PADN-HF-PH trial presented at ESC Congress 2026 and simultaneously published in NEJM.</description>
                    <pubdate>1788082020000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ADHERE-ASCVD, EMAIL-HF, Remote Exercise SWEDEHEART, VIRTUES ICD Showcase Digital Solutions</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-1215pm-innovation-esc-2026</link>                    <description>As digital health moves from promise to practice, several studies presented during a Hot Line Session at ESC Congress 2026 demonstrate how technology can accelerate the implementation of guideline-directed cardiovascular care. From digital strategies that support uptake of SGLT2 inhibitors in patients with heart failure (HF) to remotely delivered exercise programs, targeted outreach to improve statin adherence, and virtual e-health systems for ICD management, these investigations highlight the growing role of technology in optimizing patient care and outcomes.</description>
                    <pubdate>1788020160000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>